AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Cellectis S.A. American Depositary Shares
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG0084L1YD1
0.98▲ 0.01 (0.51%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
0.98
Day's Range
0.96 – 1.02
52-Week Range
0.88 – 5.45
Volume
13.4K
Avg Volume
191.2K
Share Statistics
Shares Outstanding
Employees
229
Exchange
XNAS
Listed
2015-03-25
Share count as of December 31, 2025

Cellectis S.A. American Depositary Shares (CLLS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Cellectis S.A. American Depositary Shares (CLLS)
What is Cellectis S.A. American Depositary Shares's Market Cap?
Cellectis S.A. American Depositary Shares's Market Cap is $98.3M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Enterprise Value?
Cellectis S.A. American Depositary Shares's Enterprise Value is $62.7M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Price / Sales?
Cellectis S.A. American Depositary Shares's Price / Sales is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's EV / Revenue?
Cellectis S.A. American Depositary Shares's EV / Revenue is 1.1×, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Revenue (TTM)?
Cellectis S.A. American Depositary Shares's Revenue (TTM) is $56.6M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Net Income (TTM)?
Cellectis S.A. American Depositary Shares's Net Income (TTM) is -$65.3M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Diluted EPS (TTM)?
Cellectis S.A. American Depositary Shares's Diluted EPS (TTM) is -0.65, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Net Debt?
Cellectis S.A. American Depositary Shares's Net Debt is -$35.6M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CLLSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Jun 30, 2025
Profit or loss [abstract]
Revenues
Other income
Total revenues and other income
Operating expenses
Research and development expenses
Selling, general and administrative expenses
Other operating income
Total operating expenses and other operating income
Operating loss
Financial income
Financial expenses
Income tax
Net income (loss)
Basic / Diluted net income (loss) per share attributable to shareholders of Cellectis
Basic net income (loss) attributable to shareholders of Cellectis, per share ($ /share)
Diluted net income (loss) attributable to shareholders of Cellectis, per share ($ /share)